Company intelligence / Profile preview

St George Street Capital

Harpenden, England, United Kingdomsgscapital.org ↗

Ownership: Private
Employees: ~5
Development stage: Phase 2

Overview

The charity takes clinic-ready assets that have stalled in development pipelines and funds clinical trials to progress them to patients with unmet medical needs. They have an agreement with AstraZeneca to develop compounds for idiopathic male infertility and renal transplant rejection.

Therapeutic areas: Men's HealthImmunologyEndocrinologyInfectious Diseases
Modalities: Small molecules (repurposed compounds)
Industry: Academic Hospital/University/Research

Drug pipeline

1 asset

AZD1656

Phase 2

Indications: COVID-19 in diabetic patients

Partnerships

AstraZenecaExcalibur Medicines Ltd

Beyond the preview

Go deeper on St George Street Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on St George Street Capital.

Explore the full profile